FILLUNAR
LIVE

Serial Number

79428897

Owner

BIONT Co., Ltd.

Attorney

Brian P. Gregg

Filing Date

May 13, 2025

Add to watchlist:

No watchlists yet
View on USPTO

FILLUNAR Trademark

Serial Number: 79428897 • Registration: 8278998

FILLUNAR is a trademark filed by BIONT Co., Ltd. on May 13, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BIONT Co., Ltd. (3 trademarks)

#B138, B-dong,

Entity Type: 03

Trademark Details

Filing Date

May 13, 2025

Registration Date

June 2, 2026

Published for Opposition

April 14, 2026

Goods & Services

Antiseptic preparations; medical hyaluronic acid in ampoule form for pharmaceutical purposes; drug delivery agents in the form of lyophilized formulations that facilitate the delivery of pharmaceutical preparations for the treatment of facial wrinkles and volume enhancement; medical preparations for the treatment of skin wrinkles and facial volume loss using drug delivery systems; chemical preparations for pharmaceutical use, namely, for skin wrinkles and facial volume loss using drug delivery systems; cells for medical purposes; reagents for medical use; pharmaceutical preparations for the treatment of skin wrinkles and facial volume loss using drug delivery systems; diagnostic preparations for medical purposes; medical anti-aging serum; viscous fillers for wrinkle filling or volume augmentation being medical skin grafts; nucleic acid for medical purposes; medical hyaluronic acid preparations for pharmaceutical purposes; pharmaceutical skin lotions; pharmaceutical preparations for skin wrinkles and facial volume loss using drug delivery systems; surgical transplants comprising living tissues; pharmaceutical preparations for the treatment and prevention of skin wrinkles and facial volume loss using drug delivery systems; natural biomaterials for tissue recovery for medical purposes; pharmaceutical preparations for the treatment of wrinkles; injectable medical preparations for wrinkle filling in the form of gels; injectable dermal fillers for the treatment of wrinkles in the form of gels; injectable dermal fillers; injectable pharmaceuticals for treatment of skin wrinkles and facial volume loss using drug delivery systems; injectable dermal fillers for the treatment of forehead lines, glabellar lines, temple lines, cheek volume loss, cheekbone volume loss, nasolabial folds lines, marionette lines, lip lines; pharmaceutical preparation for skin care; bandages for skin wounds; pharmaceutical preparation for scar treatment

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 2, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 8, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 18, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 9, 2026 GNFN
FINAL REFUSAL E-MAILED
Feb 9, 2026 GNFR
FINAL REFUSAL WRITTEN
Feb 9, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 7, 2026 TROA
REFUSAL PROCESSED BY IB
Dec 5, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 20, 2025 RFCS
REFUSAL PROCESSED BY MPU
Nov 20, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 2, 2025 RFCR
NON-FINAL ACTION WRITTEN
Oct 1, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 25, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 5, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 31, 2025 REPR